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INTRODUCTION
Cavernous hemangioma of the liver is the most common 
benign neoplasm, and the liver is its most common visceral site, 
having been found at that location in about 19% of cases in one 
series.
1 It is usually found incidentally during a radiologic 
workup. However, it can result in specific symptoms or manifest 
with large size or enlargement. Cavernous hemangiomas usually 
present as solitary well-delineated, subcapsular, discolored nodules 
that are smaller than 5 cm. They can exhibit various forms of 
pathology, such as necrosis, scarring, and calcification, some of 
which mimic the primary or metastatic malignancy.
We present herein a case of sclerosed hemangioma in a 
52-year-old man. We discuss the histopathologic features of this 
case along with another case of giant cavernous hemangioma of 
the liver.
CASE SUMMARY
A 52-year-old male was transferred to our hospital for surgery 
of liver mass. He had visited an affiliated hospital of our uni-
versity and had undergone surgery to repair a C-spine disc 
herniation 1 month previously. A liver mass was found during 
the preoperative workup. The initial hematologic and blood 
chemistry data were as follows: 5,100/μL white blood cell count, 
12.8 g/dL hemoglobin, 175,000/μL platelet count, 21 mg/dL 
blood urea nitrogen, 0.7 mg/dL creatinine, 4.2 g/dL albumin, 33 
IU/L aspartate aminotransferase, 40 IU/L alanine aminotransferase, 
and 0.7 mg/dL total bilirubin. He was positive for hepatitis B 
(HB) surface antigen (HBsAg) and anti-HBe, and negative for 
anti-HBs and HBeAg. The alpha-fetoprotein level was 1148.2 
ng/mL, and carcinoembryonic antigen and cancer antigen 19-9 
levels were in the normal ranges.
Dynamic computed tomography (CT) disclosed a 3.8×3.2 
×3.1 cm-sized mass with a bulging contour in the lateral segment 
of the liver that was well enhanced in the arterial phase and 
showed a subtle low density with focal capsular enhancement in 
the delayed phase. This mass demonstrated a low signal intensity 
on T1-weighted image and a high signal intensity on T2-weighted 
image. It was enhanced and washed out with low signal intensity 
in the hepatobiliary phase, making it compatible with typical 
hepatocellular carcinoma. Another enhanced mass was noted in 
segment 6, with marginal globular and gradual internal enhance-
ment on dynamic CT. Magnetic resonance image (MRI) demon-
strated a low signal intensity on T1-weighted image and a slight-
ly high signal intensity on T2-weighted image. It exhibited 
subtle marginal enhancement on delayed phase and well-demar-
cated low signal intensity on hepatobiliary phase. Based on the 
radiologic findings, hemangioma or well-differentiated hep-
atocellular carcinoma in a dysplastic nodule were suspected. 
Given the impression of two hepatocellular carcinomas, or else 
one hepatocellular carcinoma and another lesion, a left lateral 
segmentectomy and wedge resection of segment 6 were 
performed.
PATHOLOGIC FINDINGS
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Figure 1. Gross appearance of the sclerosed hemangioma. A gray-white sunken nodule is noted in the subcapsular area (A). The cut 
surface discloses a well-demarcated homogenous gray-white solid nodule, measuring 2.1  cm at its greatest dimension, with tiny red 
spots (B).
Figure 2. (A) Histologic features of the sclerosed hemangioma nodule in the right lobe. A hyalinized mass is identified from the 
surrounding liver. (B) This mass consists of collapsed vascular spaces on the rich paucicellular fibrous stroma. (C) The vascular spaces 
are easily identified on immunohistochemistry for an endothelial marker. (D) Sclerosis is highlighted with a special stain, Masson’s
trichrome (A: H-E, ×12.5; B: H-E, ×200; C: factor-VIII-related antigen, ×100, D: Masson’s trichrome, ×40).
cm. A bulging mass lesion was present that measured 3.5×2.7 
cm. On sectioning, the mass was well circumscribed from the 
surrounding noncirrhotic liver and its cut surface was yellow-
ish/greenish-gray in color. Microscopic examination disclosed a 
hepatocellular carcinoma of Edmondson-Steiner grade II with 
foci of portal vein invasion.
The wedge-resected liver from segment 6 weighed 8 g 
and measured 3.8×2.8×2.0 cm. The external Glisson’s capsule 
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Figure 3. Macroscopic finding of the giant hemangioma. An externally bulging, huge, blue-red mass is noted (A). The cut section 
shows a discrete dark red, sponge-like nodule, measuring 10  cm at its greatest dimension, in the noncirrhotic liver (B).
Figure 4. Microscopic finding of the giant hemangioma. (A) Low-power view disclosing proliferation of the cavernous vascular 
structures. (B) Each vascular space is lined by flat endothelial cells and filled with fresh red blood cells. (A: H-E, ×12.5; B: H-E, 
×100).
was discolored and sunken by an underlying whitish, firm nodule 
(Fig. 1A). Sectioning revealed a relatively homogenous, 
well-circumscribed gray-white solid nodule with several d
ark-red, pin-point spots measuring 2.1×1.6 cm (Fig. 1B). 
Microscopic evaluation revealed that most areas comprised scle-
rotic hyalinized collagenous tissue with scattered tiny-to-small, 
thin-walled vascular spaces (Fig. 2A and 2B). The vascular 
spaces were frequently collapsed and lined by flat endothelial 
cells. These cells were positive on immunohistochemistry for an 
endothelial marker (Fig. 2C). There was a focal marginal zone of 
identifiable vascular spaces. Some vascular channels were sur-
rounded by a loose myxoid matrix and a concentric cuff of stel-
late cells. A special stain highlighted the sclerotic condition of 
the mass (Fig. 2D), and the surrounding nonneoplastic liver 
showed periportal fibrosis. Areas of stromal calcification were 
focally present.
DISCUSSION
Cavernous hemangiomas of the liver can be found in-
cidentally and may be readily diagnosed due to their character-
istic homogeneous hyperechogenicity and posterior acoustic en-
hancement on ultrasound examination. They can sometimes 
present different stages of involution. In these cases, radiological 
findings show atypical features,
2 occasionally mimicking malig-
nant lesions.
3 The giant size of the tumor and specific symptoms in-
cluding Kasabach-Merritt syndrome make the diagnosis difficult. 
In such cases, pathologic confirmation is needed to accurately 
characterize the lesion. 
The giant cavernous hemangioma shown in Figure 3 and 4 
was resected from a 36-year-old woman due to progressive en-
largement and multiplicity. Macroscopically, cavernous he-
mangioma presents as a subcapsular blue-red flat mass (Fig. 3A), 
with cut sections showing a homogeneous spongiform surface 
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(Fig. 3B). Areas of gray-white scarring can be present. Microscopically, 
cavernous hemangiomas comprise cavernous vascular spaces 
lined by flattened endothelium with fibrous septa (Fig. 4). 
Thrombosis and phleboliths are evident, and variable pro-
portions of scarring and calcification complicate the histopatho-
logic features.
The hemangioma is basically a type of hamartoma. Female 
sex hormones may play some role in its development and 
progression. Makhlouf and Ishak
4 compared the findings 
between sclerosed hemangioma and sclerosing cavernous 
hemangioma. According to their theory, recent hemorrhages and 
hemosiderin deposits, rich with mast cells are present in the scle-
rosing hemangioma. Moreover, fibrosis, increased elastic fibers, 
and dystrophic or psammomatous calcifications with a decreased 
number of mast cells can be observed in the sclerosed 
hemangioma. Based on these findings, they suggest the involve-
ment of the mast cells in angiogenesis, regression, and fibrosis.
The principal management of cavernous hemangioma of the 
liver is conservative. It will be helpful to understand the natural 
involution stages of this lesion. However, pathologic confirmation 
of the mass is mandatory if the possibility of malignancy cannot 
be ruled out.
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